-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
Critical -X- _ O
illness -X- _ O
due -X- _ O
to -X- _ O
2009 -X- _ O
H1N1 -X- _ O
influenza -X- _ O
has -X- _ O
been -X- _ O
characterized -X- _ O
by -X- _ O
respiratory -X- _ O
complications -X- _ O
, -X- _ O
including -X- _ O
acute -X- _ O
lung -X- _ O
injury -X- _ O
( -X- _ O
ALI -X- _ O
) -X- _ O
or -X- _ O
acute -X- _ O
respiratory -X- _ O
distress -X- _ O
syndrome -X- _ O
( -X- _ O
ARDS -X- _ O
) -X- _ O
, -X- _ O
and -X- _ O
associated -X- _ O
with -X- _ O
high -X- _ O
mortality. -X- _ O
We -X- _ O
studied -X- _ O
the -X- _ O
severity -X- _ B-Outcome
, -X- _ I-Outcome
outcomes -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
hospital -X- _ I-Outcome
charges -X- _ I-Outcome
of -X- _ O
patients -X- _ B-Patient
with -X- _ I-Patient
ALI -X- _ I-Patient
/ -X- _ I-Patient
ARDS -X- _ I-Patient
secondary -X- _ I-Patient
to -X- _ I-Patient
pandemic -X- _ I-Patient
influenza -X- _ I-Patient
A -X- _ I-Patient
infection -X- _ I-Patient
compared -X- _ O
with -X- _ O
ALI -X- _ B-Comparison
and -X- _ I-Comparison
ARDS -X- _ I-Comparison
from -X- _ I-Comparison
other -X- _ I-Comparison
etiologies. -X- _ I-Comparison
METHODS -X- _ O
: -X- _ O
A -X- _ O
retrospective -X- _ O
review -X- _ O
was -X- _ O
conducted -X- _ O
that -X- _ O
included -X- _ O
patients -X- _ O
admitted -X- _ O
to -X- _ O
the -X- _ O
Cleveland -X- _ O
Clinic -X- _ O
MICU -X- _ O
with -X- _ O
ALI -X- _ B-Patient
/ -X- _ I-Patient
ARDS -X- _ I-Patient
and -X- _ I-Patient
confirmed -X- _ I-Patient
influenza -X- _ I-Patient
A -X- _ I-Patient
infection -X- _ I-Patient
, -X- _ O
and -X- _ O
all -X- _ O
patients -X- _ B-Comparison
admitted -X- _ I-Comparison
with -X- _ I-Comparison
ALI -X- _ I-Comparison
/ -X- _ I-Comparison
ARDS -X- _ I-Comparison
from -X- _ I-Comparison
any -X- _ I-Comparison
other -X- _ I-Comparison
etiology -X- _ I-Comparison
from -X- _ O
September -X- _ O
2009 -X- _ O
to -X- _ O
March -X- _ O
2010. -X- _ O
An -X- _ O
itemized -X- _ O
list -X- _ O
of -X- _ O
individual -X- _ O
hospital -X- _ O
charges -X- _ O
was -X- _ O
obtained -X- _ O
for -X- _ O
each -X- _ O
patient -X- _ O
from -X- _ O
the -X- _ O
hospital -X- _ O
billing -X- _ O
office -X- _ O
and -X- _ O
organized -X- _ O
by -X- _ O
billing -X- _ O
code -X- _ O
into -X- _ O
a -X- _ O
database. -X- _ O
Continuous -X- _ O
data -X- _ O
that -X- _ O
were -X- _ O
normally -X- _ O
distributed -X- _ O
are -X- _ O
presented -X- _ O
as -X- _ O
the -X- _ O
mean -X- _ O
± -X- _ O
SD -X- _ O
and -X- _ O
were -X- _ O
analyzed -X- _ O
by -X- _ O
the -X- _ O
Student’s -X- _ O
t -X- _ O
test. -X- _ O
The -X- _ O
chi-square -X- _ O
and -X- _ O
Fisher -X- _ O
exact -X- _ O
tests -X- _ O
were -X- _ O
used -X- _ O
to -X- _ O
evaluate -X- _ O
differences -X- _ O
in -X- _ O
proportions -X- _ O
between -X- _ O
patient -X- _ O
subgroups. -X- _ O
Data -X- _ O
that -X- _ O
were -X- _ O
not -X- _ O
normally -X- _ O
distributed -X- _ O
were -X- _ O
compared -X- _ O
with -X- _ O
the -X- _ O
Wilcoxon -X- _ O
rank-sum -X- _ O
test. -X- _ O
RESULTS -X- _ O
: -X- _ O
Forty-five -X- _ O
patients -X- _ O
were -X- _ O
studied -X- _ O
: -X- _ O
23 -X- _ B-Patient
in -X- _ I-Patient
the -X- _ I-Patient
H1N1 -X- _ I-Patient
group -X- _ I-Patient
and -X- _ O
22 -X- _ B-Comparison
in -X- _ I-Comparison
the -X- _ I-Comparison
noninfluenza -X- _ I-Comparison
group. -X- _ I-Comparison
Mean -X- _ O
± -X- _ O
SD -X- _ O
age -X- _ O
was -X- _ O
similar -X- _ O
( -X- _ O
44 -X- _ O
± -X- _ O
13 -X- _ O
and -X- _ O
51 -X- _ O
± -X- _ O
17 -X- _ O
years -X- _ O
, -X- _ O
respectively -X- _ O
, -X- _ O
p -X- _ O
= -X- _ O
0.15 -X- _ O
) -X- _ O
. -X- _ O
H1N1 -X- _ B-Outcome
patients -X- _ I-Outcome
had -X- _ I-Outcome
lower -X- _ I-Outcome
APACHE -X- _ I-Outcome
III -X- _ I-Outcome
scores -X- _ I-Outcome
( -X- _ I-Outcome
66 -X- _ I-Outcome
± -X- _ I-Outcome
20 -X- _ I-Outcome
vs. -X- _ I-Outcome
89 -X- _ I-Outcome
± -X- _ I-Outcome
32 -X- _ I-Outcome
, -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.015 -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
had -X- _ I-Outcome
higher -X- _ I-Outcome
Pplat -X- _ I-Outcome
and -X- _ I-Outcome
PEEP -X- _ I-Outcome
on -X- _ I-Outcome
days -X- _ I-Outcome
1 -X- _ I-Outcome
, -X- _ I-Outcome
3 -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
14. -X- _ I-Outcome
Hospital -X- _ I-Outcome
and -X- _ I-Outcome
ICU -X- _ I-Outcome
length -X- _ I-Outcome
of -X- _ I-Outcome
stay -X- _ I-Outcome
and -X- _ I-Outcome
duration -X- _ I-Outcome
of -X- _ I-Outcome
mechanical -X- _ I-Outcome
ventilation -X- _ I-Outcome
were -X- _ I-Outcome
comparable. -X- _ I-Outcome
SOFA -X- _ I-Outcome
scores -X- _ I-Outcome
over -X- _ I-Outcome
the -X- _ I-Outcome
first -X- _ I-Outcome
2 -X- _ I-Outcome
weeks -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
ICU -X- _ I-Outcome
indicate -X- _ I-Outcome
more -X- _ I-Outcome
severe -X- _ I-Outcome
organ -X- _ I-Outcome
failure -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
noninfluenza -X- _ I-Outcome
group -X- _ I-Outcome
( -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.017 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Hospital -X- _ I-Outcome
mortality -X- _ I-Outcome
was -X- _ I-Outcome
significantly -X- _ I-Outcome
higher -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
noninfluenza -X- _ I-Outcome
group -X- _ I-Outcome
( -X- _ I-Outcome
77 -X- _ I-Outcome
vs. -X- _ I-Outcome
39 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.016 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
The -X- _ I-Outcome
noninfluenza -X- _ I-Outcome
group -X- _ I-Outcome
tended -X- _ I-Outcome
to -X- _ I-Outcome
have -X- _ I-Outcome
higher -X- _ I-Outcome
overall -X- _ I-Outcome
charges -X- _ I-Outcome
, -X- _ I-Outcome
including -X- _ I-Outcome
significantly -X- _ I-Outcome
higher -X- _ I-Outcome
cost -X- _ I-Outcome
of -X- _ I-Outcome
blood -X- _ I-Outcome
products -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
ICU. -X- _ I-Outcome
CONCLUSIONS -X- _ O
: -X- _ O
ALI -X- _ B-Outcome
/ -X- _ I-Outcome
ARDS -X- _ I-Outcome
secondary -X- _ I-Outcome
to -X- _ I-Outcome
pandemic -X- _ I-Outcome
influenza -X- _ I-Outcome
infection -X- _ I-Outcome
is -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
more -X- _ I-Outcome
severe -X- _ I-Outcome
respiratory -X- _ I-Outcome
compromise -X- _ I-Outcome
but -X- _ I-Outcome
has -X- _ I-Outcome
lower -X- _ I-Outcome
overall -X- _ I-Outcome
acuity -X- _ I-Outcome
and -X- _ I-Outcome
better -X- _ I-Outcome
survival -X- _ I-Outcome
rates -X- _ I-Outcome
than -X- _ I-Outcome
ALI -X- _ I-Outcome
/ -X- _ I-Outcome
ARDS -X- _ I-Outcome
due -X- _ I-Outcome
to -X- _ I-Outcome
other -X- _ I-Outcome
causes. -X- _ I-Outcome
Higher -X- _ O
absolute -X- _ O
charges -X- _ O
in -X- _ O
the -X- _ O
noninfluenza -X- _ O
group -X- _ O
are -X- _ O
likely -X- _ O
due -X- _ O
to -X- _ O
underlying -X- _ O
comorbid -X- _ O
medical -X- _ O
conditions -X- _ O
. -X- _ O

